Impact News +++ IDEANOMICS, INC.: 8-K Report (SEC Filing) +++ IDEANOMICS Aktie +3,45%

BRISTOL-MYERS Aktie

>BRISTOL-MYERS Aktienkurs

55.91 EUR +0.3% (Tradegate)

Ask: 56.20 EUR / 150 Stück

Bid: 56.03 EUR / 150 Stück

Tagesumsatz: 2944 Stück

Realtime Kurs von 8 bis 22 Uhr!

Intraday

1 Jahr

>BRISTOL-MYERS Performance

1 Woche: +1,0%

1 Monat: +3,3%

3 Monate: +8,0%

6 Monate: +10,5%

1 Jahr: +10,6%

laufendes Jahr: +10,8%

>BRISTOL-MYERS Aktie

Name:

BRISTOL-MYERS SQUIBBDL-10

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US1101221083 / 850501

Symbol/ Ticker:

BRM (Frankfurt) / BMY (NYSE)

Kürzel:

FRA:BRM, BRM.F, BRM:GR, NYSE:BMY

Index:

S&P500

Webseite:

https://www.bms.com/

Marktkapitalisierung:

125290 Mio. EUR

Umsatz:

35642.48 Mio. EUR

EBITDA:

15269.4 Mio. EUR

Gewinn je Aktie:

-1.898 EUR

Schulden:

39355.75 Mio. EUR

Liquide Mittel:

10940.02 Mio. EUR

Umsatz-/ Gewinnwachstum:

2.7% / -

KGV/ KGV lG:

- / 8.42

KUV/ KBV/ PEG:

2.93 / 3.31 / 1.09

Gewinnm./ Eigenkapitalr.:

-14.53% / -14.15%

Dividende je Aktie:

1.602 EUR

Dividendenrendite/ -schätzung:

2.9% / 2.94%

Div. Historie:

31.03.21 - 0.41819€
31.12.20 - 0.39846€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

BRISTOL-MYERS, BRISTOL MYERS

Letzte Datenerhebung:

16.06.21

>Eigentümer

Aktien: 2230 Mio. St.

f.h. Aktien: 2200 Mio. St.

Insider Eigner: 0.07%

Instit. Eigner: 74.95%

Leerverk. Aktien: 0.75%

>Anleihen

Es sind 14 Anleihen zur BRISTOL-MYERS Aktie bekannt.

>Peer Group

ABBVIE

AMGEN

BIOGEN

CELSION

FRESENIUS ADR

MORPHOSYS ADR

OTONOMY

SIEMENS HEALTHINEERS ADR

TELADOC

TILRAY

>BRISTOL-MYERS Chart & Kurs - NYSE

>BRISTOL-MYERS News

18.06.21 - 05:37	Bristol Myers Enters Into Collaboration For Eisai′s MORAb-202 Antibody Drug Conjugate (AFX)
	NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Co. (BMY) and Eisai Co., Ltd. have reached a strategic collaboration agreement for the co-development and co-commercialization of MORAb-202, an antib......

18.06.21 - 01:22	UPDATE 1-Bristol-Myers, Eisai in up to $3.1 bln deal to develop cancer drug candidate (Reuters EN)
	...(Adds details on agreement, background) June 17 (Reuters) - Bristol......

18.06.21 - 00:58	Bristol-Myers and Eisai to jointly develop, market cancer drug (Reuters EN)
	...(Reuters) - Bristol-Myers Squibb Co and Eisai Co on Thursday......

18.06.21 - 00:48	Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know (Zacks)
	Bristol Myers Squibb (BMY) closed at $66.77 in the latest trading session, marking a -0.22% move from the prior day....

17.06.21 - 22:21	Bristol-Myers Squibb Company declares $0.49 dividend (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

17.06.21 - 22:19	Bristol Myers Squibb Announces Dividend (Business Wire EN)
	NEW YORK--(BUSINESS WIRE)---- $BMY--Bristol Myers Squibb Announces Dividend...

15.06.21 - 22:22	OpenText Appoints Ann M. Powell to Board of Directors (PR Newswire)
	WATERLOO, Ontario, June 15, 2021 /PRNewswire/ -- OpenText™ (NASDAQ: OTEX), (TSX: OTEX), today announced the appointment of Ann M. Powell to its board of directors. Ms. Powell is the current EVP, Global Chief Human Resource Officer for Bristol Myers...

15.06.21 - 18:48	Exelixis (EXEL) & Bristol Myers Team Up for Genitourinary Cancers (Zacks)
	Exelixis (EXEL) collaborates with Bristol Myers to evaluate its next-generation tyrosine kinase inhibitor in combination with immuno-oncology therapies in advanced solid tumors....

14.06.21 - 17:57	Bristol-Myers Squibb Company (BMY) Investor Presentation - Slideshow (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.06.21 - 14:55	Exelixis, Bristol Myers To Evaluate XL092-Immuno-oncology Therapies In Advanced Solid Tumors (AFX)
	NEW YORK CITY (dpa-AFX) - Exelixis Inc. (EXEL) said Monday that it has reached a clinical trial collaboration and supply agreement with Bristol-Myers Squibb Co. (BMY) for STELLAR-002, a new phase ......

14.06.21 - 14:36	Exelixis inks collaboration and supply agreement with Bristol Myers Squibb for cancer study (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.06.21 - 13:03	Bristol Myers Squibb Stock Remains Undervalued After Positive Data From Clinical Trials (Forbes)
	The stock price of Bristol Myers Squibb (NYSE: BMY) has seen a 3% rise in yesterday's trading session (Jun 10), after the company announced positive data from phase three clinical trials of Breyanzi as a second line treatment in adults with relapsed...

13.06.21 - 15:06	How Big Is Bristol Myers Squibb′s Latest FDA Approval? (Fool)
	It's an important win for a drug gained in the Celgene acquisition to reach blockbuster status....

12.06.21 - 00:48	Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know (Zacks)
	Bristol Myers Squibb (BMY) closed the most recent trading day at $67.34, moving -0.07% from the previous trading session....

11.06.21 - 19:33	Bristol Myers (BMY) Announces Data on CAR T Cell Therapy Breyanzi (Zacks)
	Bristol Myers (BMY) announces positive data on CAR T cell therapy, Breyanzi, in the second-line setting for patients with relapsed or refractory large B-cell lymphoma....

11.06.21 - 15:15	Bristol-Myers Squibb: Undervalued, With 13% Upside (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

11.06.21 - 13:03	Bristol Myers, Acceleron′s Reblozyl shows encouraging action in adults with beta thalassemia (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

11.06.21 - 12:07	BMY, Acceleron Announce New Data From Reblozyl Phase 2 Trial For Adults With NTD Beta Thalassemia (AFX)
	NEW YORK CITY (dpa-AFX) - Bristol Myers Squibb (BMY) and Acceleron Pharma Inc. (XLRN) announced Friday the first data from the Phase 2 BEYOND study evaluating Reblozyl (luspatercept-aamt), a first......

11.06.21 - 07:00	Bristol-Myers Squibb - Don′t Miss Out On This (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

10.06.21 - 21:36	Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript) (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Zitat des Tages: Hungriges Pferd macht die Krippe sauber. - Sprichwort Frankreich

Partner: >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf Twitter |

Börsentreff auf Instagram